METABOLIC SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Normuradov Alisher Ismailovich, Uralov Rustam Sherbekovich

Authors

Normuradov Alisher Ismailovich, Uralov Rustam Sherbekovich Samarkand State Medical University, Samarkand, Uzbekistan Author

Keywords:

autoimmune inflammation, systemic lupus erythematosus, metabolic syndrome, atherosclerosis

Abstract

Goal. To characterize the metabolic syndrome (MT) in patients with SLE and clarify the contribution of immune inflammation to the development of the latter.

Materials and methods. 154 wives were examined. with SLE, MS. age 35 years, duration of the disease 99 months. The control group consisted of 69 people. without rheumatic diseases of comparable age. The APR III criteria were used to diagnose MS. The detection of atherosclerotic vascular lesions was carried out by ultrasound scanning of the carotid arteries. The concentration of cholesterol, TG, and HDL cholesterol in the blood serum was determined by colorimetric and photometric methods, the levels of hs-CRP is an immunonephelometric method.

Results. MS was diagnosed in 29/154 (19%) patients with SLE and in 5/69 (7%) in the control group (p=0.02). The incidence of MS components: hypertension, HTG, and hypoalphalipoproteinemia was significantly higher in patients with SLE than in the control group. In SLE, the levels of TG, HDL-C, and CRP exceeded the values of these indicators in healthy individuals. The thickness of the carotid artery CMM in SLE and in the control was the same, ATB and coronary artery disease were more often detected in SLE (15% and 14%) than in the control (4% and 2%), (p=0.01). Patients with SLE and MS were older in age, with higher the values of disease activity, IP, and the maximum dose of HC during the disease period (p<0.05). The concentration of CRP was significantly higher in patients with SLE and MS. Subclinical manifestations of atherosclerosis were more often diagnosed in patients SLE and MS compared with patients with SLE without MS (p<0.05). There were no differences in the frequency of detection of clinical manifestations of atherosclerosis between the groups.

References

1.Авазова, Т. А., & Хаитова, Н. М. (2011). ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ ПРЕПАРАТА" TAF" ЛАКТОФЛОР У БОЛЬНЫХ МЕТАБОЛИЧЕСКИМ СИНДРОМОМ. Врач-аспирант, 49(6.1), 209-212.

2.Avazova, T., & Rogelio, P. (2024). Effects of Ursodeoxycholic Acid on Inflammatory Markers IL-6 and IL-17 in Patients with Metabolic Syndrome. Frontiers of Global Science, 2(1), 12-16.

3.Avazova, T., Khaitova, N., & Ismailova, A. (2013). Significance of IL-6 and IL-17 cytokines in diagnostics and prognosis of the metabolic syndrome. Medical and Health Science Journal, 14(1), 40-45.

4.Авазова, T. (2012). Метаболический синдром (обзор литературы). Журнал вестник врача, 1(3), 217-219.

5.Ismailova, A. A., Uralova, S. A., Nigmatova, L. M., Adylov, D. G., Petrova, T. A., Nabieva, U. P., & Avazova, T. A. (2017). The optimization of technique of detection of cryoglobulins in conditions of clinical diagnostic laboratory. Klinicheskaia Laboratornaia Diagnostika, 62(1), 50-52.

6.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT KASALLIGIDA METABOLIK REGULYASIYA. Научный Фокус, 2(19), 429-434.

7.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRITDA STEROID DIABET OLDINI OLISH. Научный Фокус, 2(19), 425-428.

8.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT KASALLIGIDA METORTRIT VA NOSTEROIDLARNI BIRGA QOLLASHDA TERAPEVTIK SAMARADORLIK. Научный Фокус, 2(19), 418-424.

9.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). TIZIMLI QIZIL YUGURIK KASALLIGI. Научный Фокус, 2(19), 413-417.

10.Uralov, R. S., Omonov, S. A., & Zaripov, J. S. SOME INDICATORS OF THE HEMOSTASIS SYSTEM IN THROMBOCYTOPENIA OF DRUG AND NON-DRUG GENESIS IN THE CLINIC INTERNAL DISEASES. УЧЕНЫЙ XXI ВЕКА, 28(10), 79-88.

11.Uralov, R. S., Omonov, S. A., & Zaripov, J. S. SOME INDICATORS OF THE HEMOSTASIS SYSTEM IN THROMBOCYTOPENIA OF DRUG AND NON-DRUG GENESIS IN THE CLINIC INTERNAL DISEASES. УЧЕНЫЙ XXI ВЕКА, 28(10), 79-88.

12.Gazkhanovna, M. A., Khaidarovna, M. F., & Ugli, U. R. S. (2020). Clinical And Electro-Neuromyographic Changes In The Pathology Of The Muscular System In Patients With Hemophilia. The American Journal of Medical Sciences and Pharmaceutical Research, 2(11), 53-56.

13.Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., & Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control Study. International journal of health sciences, 6(S10), 175-182.

14.Абдушукурова, К. Р., Исламова, К. А., Хамраева, Н. А., & Уралов, Р. Ш. (2023). ФФЕКТИВНОСТЬ ЛЕЧЕНИЯ РЕВМАТОИДНОГО АРТРИТА. IQRO, 2(2), 194-200.

15.Тоиров, Э., Исломова, К., & Уралов, Р. (2019). Эффективность комплексного лечения раннего остеоартроза. Журнал вестник врача, 1(3), 99-103.